Home Tools
Log in
Cart

Search Result

Search Results for " aldo-keto "

14

Compounds

Cat No. Product Name Synonyms Targets
T38684 AKR1C3-IN-4 AKR1C3-IN-4 NADPH
AKR1C3-IN-4 is a potent and selective inhibitor of aldo-keto reductase 1C3 (AKR1C3) with an IC50 of 0.56 μM. AKR1C3-IN-4 has the potential for castrate resistant prostate cancer (CRPC) research.
T39635 Obafistat NADPH
Obafistat is a potent inhibitor of aldo-keto reductase AKR1C3 with an IC50 of 1.2 nM for human AKR1C3.
T67950 S19-1035 NADPH
S19-1035 is a potent and specific inhibitor of aldo-keto reductase 1C3 (AKR1C3), displaying an inhibitory concentration (IC50) of 3.04 nM. It is primarily utilized in tumor research.
T67846 AKR1C3-IN-9 NADPH
AKR1C3-IN-9 is a selective Aldo-keto Reductase 1C3 (AKR1C3) inhibitor (IC50= 8.92 nM). AKR1C3-IN-9 can significantly reverse the Doxorubicin (DOX) resistance in a resistant breast cancer cell line.
T27990 MDK-0738 AKR1C3-IN-14a,AKR1C3 IN 14a
MDK-0738 is a potent and selective aldo-keto reductase 1C3 inhibitor.
T26196 SN34037 SN-34037,SN 34037
SN34037 is a specific Aldo-keto reductase 1C3 (AKR1C3, EC 1.1.1.188) inhibitor.
T69859 Obafistat Na
Obafistat Na is an aldo-keto reductase AKR1C3 inhibitor.
T22388 OBI-3424 Others
OBI-3424, a highly selective prodrug, is converted by aldo-keto reductase family 1 member C3 (AKR1C3) to a potent DNA-alkylating agent.
T39594 AKR1B10-IN-1 AKR1B10-IN-1
AKR1B10-IN-1, a powerful AKR1B10 (Aldo-Keto Reductase 1B10) inhibitor, demonstrates an IC50 value of 3.5 nM. This compound effectively curtails the proliferation, metastasis, and Cisplatin (CDDP) resistance of lung cance...
T61003 S07-2009
S07-2009 is a potent and selective inhibitor of aldo-keto reductase 1C3 (AKR1C3) (IC 50 = 0.20 μM) [1].
T62373 S07-2008
S07-2008 is a selective inhibitor of aldo-keto reductase family 1 member C3 (AKR1C3) (IC50: 0.16 μM) and has anticancer effects.
T61511 S07-2005 (racemic)
S07-2005 racemic is a chemically potent and selective inhibitor of aldo-keto reductase 1C3 (AKR1C3), with an IC50 value of 0.13 μM and 0.75 μM for AKR1C3 and AKR1C4, respectively. Due to its inhibitory properties, it exh...
T78199 S07-1066 Others
S07-1066, an aldo-keto reductase 1C3 (AKR1C3) inhibitor, enhances doxorubicin (DOX) cytotoxicity by selectively inhibiting AKR1C3-mediated reduction of DOX and reversing DOX resistance in cells with elevated AKR1C3 expre...
T61033 S07-2001
S07-2001 enhances Doxorubicin against cancer cells activity, which can be used as a chemotherapeutic potentiator for cancer drug resistance. S07-2001 is a potent and selective inhibitor of aldo-keto reductase 1C3 (AKR1C3...
TargetMol